LEVI
Levi Strauss & Co.
LEVI has the edge over RIVN overall, supported by lower modeled downside and stronger fundamentals.
RIVN
Rivian Automotive, Inc.
RIVN offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
LEVI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
LEVI's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LEVI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $18.30 | -24% |
| Forward | 15x | $24.04 | — |
| Fair | 16x | $23.57 | -1.9% |
| Current | 16x | $24.04 | — |
| Expensive | 38x | $55.97 | +133% |
Historical ranges are pointers, not guarantees.
LEVI's PE is in its fair range at 16x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
LEVI Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for LEVI, with profitability improving.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LEVI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.57 | +5.2% |
| Q3 2026 | $1.49 | -2% |
| Q2 2026 | $1.61 | +58% |
| Q1 2026 | $1.56 | +75% |
| Q4 2025 | $1.45 | +179% |
| Q3 2025 | $1.52 | +311% |
| Q2 2025 | $1.02 | +200% |
| Q1 2025 | $0.89 | +197% |
| Q4 2024 | $0.52 | -16% |
LEVI has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
LEVI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +4.3% |
| Q2 2026 | $1.6B | +8% |
| Q1 2026 | $1.7B | +14% |
| Q4 2025 | $1.8B | -4% |
| Q3 2025 | $1.5B | +1.8% |
| Q2 2025 | $1.4B | +0.3% |
| Q1 2025 | $1.5B | -2% |
| Q4 2024 | $1.8B | +12% |
LEVI's revenue has picked up after three years of holding roughly level: $1.6B last quarter, up 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +3 points |
| Q2 2026 | 7.8% | +0.4 points |
| Q1 2026 | 11% | -1.2 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 11% | +8.8 points |
| Q2 2025 | 7.5% | +5.9 points |
| Q1 2025 | 13% | +13 points |
| Q4 2024 | 12% | +2.3 points |
LEVI has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over LEVI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
LEVI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44.3M | +$83.7M |
| Q2 2026 | $230.9M | +58% |
| Q1 2026 | $152.1M | +$166.2M |
| Q4 2025 | $215.7M | -6.9% |
| Q3 2025 | -$39.4M | -1813% |
| Q2 2025 | $146M | -34% |
| Q1 2025 | -$14.1M | -107% |
| Q4 2024 | $231.6M | +14% |
LEVI has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
LEVI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.7x | Very low |
LEVI's net debt is less than a year of its operating earnings (EBITDA).
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LEVI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.3 | Neutral |
| Stochastic | 71.3 | Neutral |
LEVI's weekly RSI is 61 (neutral) and its Stochastic is 71 (neutral).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
LEVI PE vs Consumer Cyclical Sector
| Metric | LEVI | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 10% below |
| PE % | 50 | 47 | 3 pts above |
LEVI is trading at 16x earnings, a 10% discount to the Consumer Cyclical sector's median of 18x.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
LEVI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.2 | 14% above |
| 20 week MA | $22.1 | 8.7% above |
| 50 week MA | $21.8 | 10% above |
| 100 week MA | $20.3 | 18% above |
| 200 week MA | $18.7 | 29% above |
LEVI has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
LEVI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.3 | $20.6 | +7.1% |
| 2021 | $20.6 | $24.6 | +19% |
| 2022 | $24.6 | $15.5 | -37% |
| 2023 | $15.5 | $16.5 | +6.8% |
| 2024 | $16.5 | $17.2 | +3.9% |
| 2025 | $17.2 | $21.1 | +23% |
| 2026 YTD | $21.1 | $24.0 | +14% |
LEVI has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.